Target intelligence / Profile preview

Ribosomal protein L22 pseudogene 12 (RPL22P12)

Target
RPL22P12
Molecular classification
Pseudogene
01

Overview

Ribosomal protein L22 pseudogene 12 (RPL22P12) is a non-functional copy (pseudogene) of the gene encoding the human ribosomal protein L22. Pseudogenes like RPL22P12 typically arise from gene duplication or retrotransposition events and contain significant sequence similarity to their parent genes but do not produce a functional protein due to stop codons, frameshifts, or other mutations[4][5]. Although some ribosomal protein pseudogenes have been found to be transcribed, they generally do not have direct biological or therapeutic relevance and are not targeted by drugs or implicated as biomarkers[4][5]. RPL22P12 is part of a large family of ribosomal protein pseudogenes dispersed throughout the genome[5]. Key notes for curation: This gene is not a therapeutic target, receptor, or enzyme. It is categorized as a processed pseudogene based on sequence analysis. No evidence exists supporting a functional role, interaction with drugs, or disease association for RPL22P12 specifically. RPL22P12 should not be confused with the functional ribosomal protein L22 (RPL22), which is a genuine structural component of the ribosome[1][2].

Beyond the preview

Go deeper on Ribosomal protein L22 pseudogene 12 (RPL22P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L22 pseudogene 12 (RPL22P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call